Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Dover Corp (DOV) vs Hims and Hers Health Inc (HIMS) Price & Performance

Dover CorpTrade
Hims and Hers Health IncTrade

Price performance (Past 24H)

Key statistics

Dover Corp vs Hims and Hers Health Inc — how do they compare? Dover Corp trades at $207.87 (market cap $28.07B), while Hims and Hers Health Inc trades at $29.7 (market cap $7.12B). The key difference: Dover Corp is far larger — about 3.9× Hims and Hers Health Inc's market cap, and Dover Corp pays a 1.01% dividend while Hims and Hers Health Inc pays none. Which is the better fit depends on your goals.

DOVHIMS
Market Cap
$28.07B$7.12B
Sector
IndustrialsHealth
52-Week High
$233.31$62.76
52-Week Low
$161.16$14.52
Enterprise Value
$29.58B$7.82B
Dividend Yield
1.01%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Dover Corp

Dover Corporation (DOV) trades at $210.1, down 0.49% on the day, with a bullish technical signal and consistent earnings beats in recent quarters. The company reported strong Q2 2026 results with EPS of $2.74, exceeding expectations, and raised full-year guidance. Recent dividend increases and strategic acquisitions, such as Cloeren, highlight management's confidence in growth. Valuation ratios like P/E of 25.21 and ROE of 14.98% reflect solid profitability, though the stock faces resistance near $212.

The outlook for DOV is positive, driven by robust fundamentals and analyst consensus favoring a buy rating with a $232.33 price target. Risks include market volatility and execution challenges from acquisitions, but diversified end-market exposure and margin expansion support upside potential for investors seeking steady income and growth.

Hims and Hers Health Inc

HIMS stock declined 7.11% to $29.51 following mixed Q2 2026 results, where revenue beat expectations but the company posted a wider-than-expected loss. The technical picture is neutral with bearish moving average signals, while fundamentals show strong revenue growth but deteriorating margins. Recent news highlights margin pressure from GLP-1 drug investments and an FTC investigation, creating investor uncertainty despite raised revenue guidance.

The outlook remains cautious as strong subscriber growth and AI initiatives are offset by profitability challenges and regulatory scrutiny. Investment opportunity exists in the company's expanding global footprint and raised revenue targets, but risks include margin compression, negative cash flow trends, and ongoing legal investigations that could pressure the stock near-term.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Dover Corp

Dover is a diversified industrial manufacturing company with products and services that include digital printing for fast-moving consuming goods, marking and coding for the food and beverage industry, loaders for the waste collection industry, pumps for the transport of fluids, including petroleum and natural gas, and commercial refrigerators used in groceries and convenience stores. Most of the business operates in the United States. After the spinoff of Apergy, the company operates through five segments: engineered systems, clean energy and fueling solutions, imaging and identification, pumps and process solutions, and climate and sustainability technologies equipment.

Read more on DOV

About Hims and Hers Health Inc

Hims & Hers is a multi-specialty telehealth platform that provides personalized health and wellness products. It offers access to medical providers and treatments for hair loss, sexual health, and skincare.

Read more on HIMS